Celltrion
068270.KS
#830
Rank
NZ$48.30 B
Marketcap
NZ$220.79
Share price
0.54%
Change (1 day)
2.12%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Number of shares outstanding for Celltrion (068270.KS)

Number of shares outstanding as of December 2025 : 219,292,284

According to Celltrion 's latest financial reports and stock price the company's current number of shares outstanding is 219,292,284. At the end of 2025 the company had 219,292,284 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Celltrion from 2023 to 2025

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20250.21 B-10.61%
20240.24 B58.29%
20230.15 B-4.87%
20220.16 B